We're planning to attend the FDA's upcoming virtual town hall on #CellTherapy CMC Readiness for Late-Stage INDs, scheduled for 05 September 2024. Our team will review the information presented and be prepared to offer feedback as needed. If you are engaged in cell therapy development, make sure to tune in to hear more from FDA on this important topic. Contact an expert on our team: Nathan Blazei, Ryan M. Doxey Follow Kymanox: https://lnkd.in/e35y_dQq Get in Touch: kymanox.com
@FDACBER is hosting a #virtual town hall on 9/5 to answer questions related to CMC readiness for late-stage INDs for #CellTherapy and tissue-engineered products. Register today and submit questions to #FDA experts in advance of this event. https://bit.ly/3LqCoSs